Scienture Holdings, Inc.
SCNX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | – | -100% | -80.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | -$0 | $0 | $0 |
| % Margin | 97.4% | – | 6.6% | 5.3% |
| R&D Expenses | $0 | $1 | $1 | $1 |
| G&A Expenses | $3 | $0 | $3 | $3 |
| SG&A Expenses | $3 | $4 | $3 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | $0 | $0 | $0 |
| Operating Expenses | $4 | $5 | $4 | $4 |
| Operating Income | -$4 | -$5 | -$4 | -$4 |
| % Margin | -611.4% | – | -34,814.9% | -7,939.6% |
| Other Income/Exp. Net | $0 | -$2 | $1 | -$3 |
| Pre-Tax Income | -$4 | -$7 | -$3 | -$7 |
| Tax Expense | $0 | $0 | $0 | -$1 |
| Net Income | -$4 | -$7 | -$3 | -$7 |
| % Margin | -611.4% | – | -29,869.3% | -13,493.5% |
| EPS | -0.19 | -0.475 | -0.33 | -0.82 |
| % Growth | 60% | -44% | 59.8% | – |
| EPS Diluted | -0.19 | -0.475 | -0.33 | -0.82 |
| Weighted Avg Shares Out | 19 | 14 | 9 | 9 |
| Weighted Avg Shares Out Dil | 19 | 14 | 9 | 9 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $1 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$6 | -$2 | -$6 |
| % Margin | -304.5% | – | -23,183.7% | -11,883.9% |